|
US2735225A
(en)
|
|
1956-02-21 |
|
Table ix p petri dish tests with x-phthalimido- |
|
DE2253251A1
(de)
|
1972-10-30 |
1974-05-09 |
Thomae Gmbh Dr K |
Neue phthalimido-sulfonylharnstoffe
|
|
EP0145078B1
(en)
*
|
1983-12-02 |
1988-10-12 |
Shell Internationale Researchmaatschappij B.V. |
Diphenyl ether herbicides
|
|
FR2659327A1
(fr)
|
1990-03-08 |
1991-09-13 |
Centre Nat Rech Scient |
Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
|
|
ATE162525T1
(de)
|
1991-07-30 |
1998-02-15 |
Ciba Geigy Ag |
Heteroaryl substituierte hydroxylaminderivate als lipoxygenase-inhibitoren
|
|
US5350761A
(en)
*
|
1991-07-30 |
1994-09-27 |
Ciba-Geigy Corporation |
Indolyl substituted hydroxylamine derivatives
|
|
US5334600A
(en)
*
|
1991-07-30 |
1994-08-02 |
Ciba-Geigy Corporation |
Isoquinolyl substituted hydroxylamine derivatives
|
|
TW219935B
(enExample)
*
|
1991-12-25 |
1994-02-01 |
Mitsubishi Chemicals Co Ltd |
|
|
US5599811A
(en)
*
|
1995-02-21 |
1997-02-04 |
Warner-Lambert Company |
Benzothiazine dioxides as endothelin antagonists
|
|
EP0891332B1
(en)
|
1996-03-29 |
2004-03-17 |
Pfizer Inc. |
6-phenylpyridyl-2-amine derivatives
|
|
US6716836B2
(en)
|
2001-03-22 |
2004-04-06 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
|
GB0124627D0
(en)
*
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE10348022A1
(de)
|
2003-10-15 |
2005-05-25 |
Imtm Gmbh |
Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
TW200613272A
(en)
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
|
WO2006038594A1
(ja)
*
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
Ｎ型カルシウムチャネル阻害薬
|
|
US8110681B2
(en)
|
2006-03-17 |
2012-02-07 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compounds for the treatment of spinal muscular atrophy and other uses
|
|
NZ577981A
(en)
*
|
2006-12-27 |
2011-12-22 |
Sanofi Aventis |
Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
|
|
AU2008218951B2
(en)
*
|
2007-02-22 |
2011-11-17 |
Irm Llc |
Compounds and methods for modulating g protein-coupled receptors
|
|
US8569378B2
(en)
|
2007-07-20 |
2013-10-29 |
Toshiyuki Sakai |
p27 protein inducer
|
|
CA2740366A1
(en)
|
2008-10-21 |
2010-04-29 |
Metabolex, Inc. |
Aryl gpr120 receptor agonists and uses thereof
|
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
US8362052B2
(en)
*
|
2009-03-11 |
2013-01-29 |
Msd K.K. |
Isoindolin-1-one derivative
|
|
US8314120B2
(en)
|
2010-03-30 |
2012-11-20 |
Abbott Gmbh & Co. Kg |
Small molecule potentiators of metabotropic glutamate receptors
|
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
|
CA2801182A1
(en)
|
2010-06-16 |
2011-12-22 |
Metabolex, Inc. |
Gpr120 receptor agonists and uses thereof
|
|
TW201200505A
(en)
*
|
2010-06-17 |
2012-01-01 |
Metabolex Inc |
GPR120 receptor agonists and uses thereof
|
|
EP2731944A1
(en)
|
2011-07-15 |
2014-05-21 |
Pfizer Inc |
Gpr 119 modulators
|
|
EA035454B1
(ru)
|
2011-11-30 |
2020-06-18 |
Ф.Хоффманн-Ля Рош Аг |
Бициклические производные дигидроизохинолин-1-она
|
|
RU2015116540A
(ru)
|
2012-10-11 |
2016-12-10 |
Мерк Шарп И Доум Корп. |
Замещенные соединения спиропиперидинила, применяемые в качестве агонистов gpr120
|
|
KR101942752B1
(ko)
*
|
2012-11-05 |
2019-01-28 |
주식회사 엘지화학 |
Ｇｐｒ120 효능제로서의 티오아릴 유도체
|
|
CA2893239A1
(en)
|
2012-12-03 |
2014-06-12 |
F. Hoffmann-La Roche Ag |
Substituted triazole and imidazole compounds
|
|
US9714252B2
(en)
|
2012-12-20 |
2017-07-25 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
WO2014159061A2
(en)
*
|
2013-03-14 |
2014-10-02 |
Janssen Pharmaceutica Nv |
Benzo-fused heterocyclic derivatives useful as agonists of gpr120
|
|
AU2014237600B2
(en)
*
|
2013-03-14 |
2018-03-22 |
Janssen Pharmaceutica Nv |
Bicyclic pyrrole derivatives useful as agonists of GPR120
|
|
DK3013796T3
(da)
|
2013-06-27 |
2020-03-16 |
Lg Chemical Ltd |
Biarylderivater som gpr120-agonister
|
|
AR099937A1
(es)
|
2014-04-04 |
2016-08-31 |
Sanofi Sa |
Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
|
|
BR112016024936A2
(pt)
|
2014-05-07 |
2017-08-15 |
Bristol Myers Squibb Co |
moduladores de gpr40 à base de pirrolidina para tratamento de doenças como diabetes
|
|
CN107074817B
(zh)
*
|
2014-08-29 |
2023-12-15 |
Chdi基金会股份有限公司 |
用于成像亨廷顿蛋白的探针
|
|
JP6486699B2
(ja)
|
2015-01-29 |
2019-03-20 |
国立大学法人金沢大学 |
脱水縮合剤
|
|
US10457669B2
(en)
*
|
2015-10-21 |
2019-10-29 |
Otsuka Pharmaceutical Co., Ltd. |
Benzolactam compounds as protein kinase inhibitors
|
|
CA3041038A1
(en)
*
|
2016-09-12 |
2018-03-15 |
Numerate, Inc. |
Bicyclic compounds useful as gpr120 modulators
|
|
JP7086942B2
(ja)
*
|
2016-09-12 |
2022-06-20 |
インテグラル ヘルス， インコーポレイテッド |
Ｇｐｒ１２０モジュレーターとして有用な単環式化合物
|